HOME >> BIOLOGY >> NEWS
Silenced gene suggests greater risk, possible marker for African-Americans with prostate cancer

Among African-Americans with prostate cancer, a tumor-suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians, according to a study conducted at the San Francisco VA Medical Center (SFVAMC).

"This could be one of the mechanisms for the higher incidence of prostate cancer in African-Americans compared to Caucasians," said Rajvir Dahiya, PhD, Director of the Urology Research Center at SFVAMC and the principle investigator of the study. "When tumor suppression activity goes down, the tumor progresses much faster."

In the United States, African-Americans have almost 1.7 times the incidence and mortality of prostate cancer compared to Caucasians (272 per 100,000 vs. 164 per 100,000, respectively).

Researchers found that the GSTP1 gene is temporarily inactivated, or "silenced," through the process of hypermethylation, in which methyl groups (CH3) replace hydrogen atoms (H) in cytosine, one of the four protein bases of the gene's DNA.

The study is the first to investigate and discover ethnic differences in GSTP1 hypermethylation between African-Americans, Caucasians, and Asians. It is being published in the August 20, 2005 issue of the International Journal of Cancer, currently available online.

The researchers noted that "in the African-American population, GSTP1 methylation is a particularly good biomarker" for prostate cancer, since it is more likely to indicate the presence of the disease than in other ethnic groups. Thus, for African-Americans, it is both a potential cause of disease and a tool for diagnosing it, according to Dahiya, who is also a professor of urology at the University of California, San Francisco (UCSF).

Although the researchers gathered their data using pathology samples, GSTP1 can be measured in body fluids. Dahiya says that for African-Americans with high levels of GSTP1 hypermethylation, appropriate treatment strategies would include more aggressive treatment
'"/>

Contact: Steve Tokar
steve.tokar@ncire.org
415-221-4810 x5202
University of California - San Francisco
16-Jun-2005


Page: 1 2 3

Related biology news :

1. Silenced gene in worm shows role in regeneration
2. New study suggests Concord grape juice may provide protection against breast cancer
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Experiment suggests limitations to carbon dioxide tree banking
5. Immunity in social amoeba suggests ancient beginnings
6. New model for autism suggests women carry the disorder and explains age as a risk factor
7. Pediatric ritalin use may affect developing brain, new study suggests
8. Oldest DNA ever recovered suggests earth was warmer than previously believed
9. Tick-related disease thrives on cholesterol, study suggests
10. Study suggests other causes for childhood brain aneurysms
11. New study suggests potential for a broadly-protective HIV vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... , ... May 20, 2020 , ... ... manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, ... Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which ...
(Date:5/21/2020)... STONEHAM, Mass. (PRWEB) , ... May 21, 2020 ... ... innovative orthopedic care across the North Shore and Greater Boston area, is pleased ... experience. , As one of the busiest group practices in the area, Agility ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... that helps Life Science Manufacturers accurately and easily project contracted liabilities with ... of Gross-to-Net models by projecting discounts/rebates to Commercial and Government entities, Copay ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , ... today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. ... studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level ...
(Date:6/23/2020)... ... June 22, 2020 , ... Regen Suppliers, the one stop ... buy three, get the fourth unit free with no limit on the amniotic ... as exosomes, have been a game changer for regenerative therapies. The products are ...
(Date:6/23/2020)... PORTLAND, Ore. (PRWEB) , ... June 23, 2020 ... ... advancement of innovative CNS therapies, today announced that it has filed an Investigational ... initiate a Phase 2b clinical trial of its lead drug candidate NBTX-001 in ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... platform delivered through the use of proprietary clean viral vectors, recently announced a ... United States. Greffex’s platform is the world’s most successful gene therapy delivery ...
Breaking Biology Technology:
Cached News: